These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications. Bautista JM; Wong WM; Pulliam G; Esquivel RF; Fass R Dig Dis Sci; 2005 Oct; 50(10):1909-15. PubMed ID: 16187196 [TBL] [Abstract][Full Text] [Related]
30. A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease. Simadibrata DM; Lesmana E; Fass R J Gastroenterol Hepatol; 2024 May; 39(5):796-805. PubMed ID: 38263507 [TBL] [Abstract][Full Text] [Related]
32. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis. Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis. Ang D; Zheng Q; Shi L; Tack J United European Gastroenterol J; 2018 Nov; 6(9):1294-1306. PubMed ID: 30386602 [TBL] [Abstract][Full Text] [Related]
34. [The role of potassium-competitive acid blockers in the treatment of acid-related digestive diseases]. Buzás GM Orv Hetil; 2023 Dec; 164(50):1967-1973. PubMed ID: 38108833 [TBL] [Abstract][Full Text] [Related]
35. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid. Sharma P; Yadlapati R Ann N Y Acad Sci; 2021 Feb; 1486(1):3-14. PubMed ID: 33015827 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease. Gotoh Y; Ishibashi E; Honda S; Nakaya T; Noguchi C; Kagawa K; Murakami K Medicine (Baltimore); 2020 Mar; 99(11):e19520. PubMed ID: 32176102 [TBL] [Abstract][Full Text] [Related]
37. Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease. Ota K; Takeuchi T; Higuchi K; Sasaki S; Mori Y; Tanaka H; Hakoda A; Sugawara N; Iwatsubo T; Nishikawa H Digestion; 2024; 105(1):5-10. PubMed ID: 37591209 [TBL] [Abstract][Full Text] [Related]
38. Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis. Barberio B; Visaggi P; Savarino E; de Bortoli N; Black CJ; Ford AC Neurogastroenterol Motil; 2023 Jan; 35(1):e14469. PubMed ID: 36153790 [TBL] [Abstract][Full Text] [Related]